Fundraising FoxRadioNano Therapeutics㈱
Kyoto, JP · 4 known investors
Find your way into RadioNano Therapeutics㈱
Each arrow is one introduction. Sign up to fill in the first one.
Ask Shota Ozawa to introduce you to Masatoshi Chiba
You →Shota · together at Mitsubishi Tanabe Pharma Corporation →Masatoshi
Sign up to find every way you can get introduced to RadioNano Therapeutics㈱
- Your email: who you already know at RadioNano Therapeutics㈱, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the RadioNano Therapeutics㈱ team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
RadioNano Therapeutics develops boron neutron capture therapy (BNCT), an advanced radiotherapy targeting cancer cells. The company is commercializing RN-501, a nanoparticle-enhanced therapeutic drug aimed at improving treatment safety and efficacy for cancer patients.
Founders & leadership
Investors · 4
How we know: the company's own site · Kyoto University Innovation Capital's portfolio page · Not right? Tell us
How we know: the company's own site · Not right? Tell us
Frequently asked questions
- What does RadioNano Therapeutics㈱ do?
- RadioNano Therapeutics develops boron neutron capture therapy (BNCT), an advanced radiotherapy targeting cancer cells. The company is commercializing RN-501, a nanoparticle-enhanced therapeutic drug aimed at improving treatment safety and efficacy for cancer patients.
- Who are RadioNano Therapeutics㈱'s investors?
- RadioNano Therapeutics㈱'s investors include Kyoto University Innovation Capital, Japan Science and Technology Agency, Mitsubishi UFJ Capital, DBJ Capital.
- Where is RadioNano Therapeutics㈱ headquartered?
- RadioNano Therapeutics㈱ is headquartered in Kyoto, JP.